SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • March 27th, 2003 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2003 Company IndustryThis is the Second Amendment to the License Agreement (the “Agreement”) between Sangamo BioSciences, Inc. (“Sangamo”) and Baxter Healthcare Corporation (“Baxter”), dated January 11, 2000. This Second Amendment shall be effective as of November 14, 2002.
FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENTResearch Funding Agreement • March 27th, 2003 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 27th, 2003 Company IndustryThis is the First Amendment to the Research Funding Agreement (the “Agreement”) between Sangamo BioSciences, Inc. (“Sangamo”) and Baxter Healthcare Corporation (“Baxter”), dated January 11, 2000. This First Amendment shall be effective as of November 14, 2002.